Advertisement

Research Article Free access | 10.1172/JCI116091

Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

H Shimano, N Yamada, M Katsuki, K Yamamoto, T Gotoda, K Harada, M Shimada, and Y Yazaki

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Shimano, H. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Yamada, N. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Katsuki, M. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Yamamoto, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Gotoda, T. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Harada, K. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Shimada, M. in: JCI | PubMed | Google Scholar

Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Find articles by Yazaki, Y. in: JCI | PubMed | Google Scholar

Published November 1, 1992 - More info

Published in Volume 90, Issue 5 on November 1, 1992
J Clin Invest. 1992;90(5):2084–2091. https://doi.org/10.1172/JCI116091.
© 1992 The American Society for Clinical Investigation
Published November 1, 1992 - Version history
View PDF
Abstract

We have reported that transgenic mice overexpressing rat apo E shows marked reduction of plasma cholesterol and triglyceride levels due to the disappearance of VLDL and LDL. In this study, we investigated the metabolism of plasma lipoproteins in transgenic mice. After intravenous injection, the rates of clearance of 125I-VLDL and 125I-LDL were 3.0- and 2.4-fold greater in transgenic mice than in controls, respectively. Furthermore, clearance of chylomicron remnants estimated by oral retinyl palmitate-loading test was markedly enhanced in transgenic mice. The hepatic expression of LDL receptors by immunoblot analysis was similar in both groups. These data suggest that elimination of lipoproteins containing apo B was due to enhanced clearance of these lipoproteins enriched with apo E through hepatic LDL receptors. When fed a high cholesterol diet, controls showed twofold elevation of plasma cholesterol levels with marked increases in VLDL and LDL cholesterol on gel filtration chromatography. In contrast, cholesterol-fed transgenic mice showed resistance against these increases. High cholesterol feeding decreased the activity of hepatic LDL receptors and had no effect on enhancement of chylomicron remnant clearance in transgenic mice. Thus, overexpression of apo E facilitates metabolism of lipoproteins containing apo B presumably primarily via the LDL receptor pathway and possibly through an interaction with the chylomicron remnant receptor.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (November 1, 1992): No description
Advertisement
Advertisement